Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Feb 15, 2023; 15(2): 318-331
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.318
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.318
Figure 3 The direct binding relationship between microRNA-627-5p and Wnt2.
A: Schematic illustration of the predicted binding sites between microRNA-627-5p (miR-627-5p) and Wnt2 mRNA; B: Dual luciferase reporter assays in HEK-293T cells. Experimental group: NC mimics + pcDNA-Wnt2-WT, miR-627-5p mimics + pcDNA-Wnt2-WT, NC mimics + pcDNA-Wnt2-MUT, miR-627-5p mimics + pcDNA-Wnt2-MUT; C: The transfection efficiency of miR-627-5p mimics in SW480 and HCT116 cells; D: The effects of miR-627-5p overexpression on the transcript expression levels of Wnt2 in SW480 and HCT116 cells; E: The effects of miR-627-5p overexpression on the protein expression levels of Wnt2 in SW480 and HCT116 cells. 3’ UTR: 3’-untranslated region; NS: Not significant; bP < 0.01; cP < 0.001.
- Citation: Zhao DY, Yin TF, Sun XZ, Zhou YC, Wang QQ, Zhou GY, Yao SK. microRNA-627-5p inhibits colorectal cancer cell proliferation, migration and invasion by targeting Wnt2. World J Gastrointest Oncol 2023; 15(2): 318-331
- URL: https://www.wjgnet.com/1948-5204/full/v15/i2/318.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i2.318